Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Vivita Technologies develops biomaterials for regenerative medicine, intending to alleviate the scarcity of donor organs and tissues.
Ontogen Medtech is a medical device development firm.
Biotricity is a medical technology company committed to improving healthcare by developing solutions that aid in chronic disease.
I CORDIS is a healthcare organization that offers services for treating heart failure.
Blue Marble Health is telehealth and remote therapeutic monitoring platform for aging and chronic disease management.
RICOVR Healthcare is a medical device company with ultra-sensitive rapid diagnostics platform for THC and COVID19.
Sinopia Biosciences enables data-driven drug discovery by means of multi-omics data, machine learning, network analyses, and disease models.
Respair is a medical device company that creates cutting-edge airway products to help clinicians and patients in critical care settings.
Alveolus Bio is pursuing the development of novel FDA-approved therapeutics to address chronic respiratory illnesses.
Hillhurst develops technologies enabling the therapeutic use of low-dose carbon monoxide.
Safi Biosolutions is biotechnology based company.
Rhealth is a biotechnology company that provides health management solutions based on advanced AI through a platform to hospitals.
EydisBio is the operator of a biotech platform dedicated to developing medical solutions for cancer and arthritis.
Asymmetrex is a life sciences biotechnology company that develops stem cell medicine technology.
Xylyx Bio creates effective science-based solutions for the benefit of human life and health.
Life sciences R&D, consulting and investment
Pioneering Potent, Safer Cell Therapy in and Beyond Oncology
Lazzaro Medical is to assist the millions of patients who have tracheobronchomalacia (TBM).
Starlight Cardiovascular develops a portfolio of devices to address pediatric congenital heart disease.
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders.
Perosphere Technologies is a private medical technologies company focused on developing coagulation diagnostics.
Microvascular Therapeutics is a biotechnology company specializing in ultrasound contrast and theranostics for diagnosis.
WynnVision is a technology based company.
VoluMetrix is dedicated to developing breakthrough monitoring technologies to enhance people's well-being.
National Heart has invested in 55 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
National Heart's top investment sectors include Biotechnology, Health Care, Medical Device, Medical, Life Science. The firm invests across 27 different industry categories.
Among tracked funding rounds, Cartesian Therapeutics received $130.0M in a Post Ipo Equity round. National Heart's total known invested capital is $235.7M.
National Heart's average investment size is $4.1M across its portfolio of 55 companies.
Recent National Heart portfolio additions include Vivita Technologies, Ontogen Medtech, Biotricity, I CORDIS, Blue Marble Health. These companies were founded in 2020 or later.